Outcomes · How we measure

What the curriculum is actually producing.

Most treatment outcomes are marketing in disguise. Atlas built the Arc so we — and the field — could finally see real signal: engagement, validated-instrument deltas, dropout, sustained recovery. Honest numbers, published as we have them.

Our stance

No "97% success" claims. Ever.

The recovery industry trades in inflated success rates that paper over relapse, attrition, and the patients who never made it to discharge. Atlas does not participate in that. We publish what the Arc measures, including what looks bad.

The numbers below are an early read from the first deployments of the Atlas Method across our anchor entities. They will get better as our sample grows, and we will publish them quarterly — with the dropout rate next to the engagement rate, every time.

I · Instruments5

What we measure, and how.

PHQ-9

Patient Health Questionnaire — Depression

Validated 9-item depression screen. Tracked at intake, monthly, and discharge.

Intake · Monthly · Discharge

GAD-7

Generalized Anxiety Disorder

Validated 7-item anxiety screen. Tracked at intake, monthly, and discharge.

Intake · Monthly · Discharge

AUDIT

Alcohol Use Disorders Identification Test

WHO-developed screen for alcohol risk; complemented by DAST-10 for drug use.

Intake · Quarterly

WHO-5

Wellbeing Index

5-item subjective wellbeing measure. Weekly inside the Arc.

Weekly · in-Arc

PCL-5

PTSD Checklist for DSM-5

20-item trauma symptom measure. Trauma-affected clients only, monthly.

Monthly · indicated

Arc · 365

Engagement signal

Day-by-day curriculum completion — sections opened, journals submitted, breath practices completed. Measured passively as patients use the Arc.

Daily · automatic

II · SignalQ1

Q1 2026 · early read.

Cohort engagement · 90-day

83%

Median daily completion across the first deployments at NIRC, Prairie/Lovett, and Millennium.

PHQ-9 Δ · 90-day

−4.8

Median improvement in depression score from intake to day 90. Clinically meaningful threshold: −5.

GAD-7 Δ · 90-day

−3.6

Median improvement in anxiety score from intake to day 90.

Attrition · 90-day

14%

Patients who left care or stopped engaging the Arc before day 90. Industry average: ~30–50%.

N = 124 patients · sites: 3 · methodology: median, not mean — to control for outliers; intent-to-treat (attrition counted).

III · What we don't—

What we will not claim.

Five numbers you will never see on this page.

"Sobriety success rate." Recovery is not a binary. Anyone publishing a single rate is hiding either the denominator or the timeframe.
"Customer satisfaction." A 5-star rating from someone in residential care under contract pressure is not a clinical outcome.
"Industry-leading" anything. The industry's leading numbers are mostly fiction. We don't grade on that curve.
Cohort-cherrypicking. We don't filter the cohort to the patients who finished. Dropouts count — including the ones we drove away.
Pre/post within the program. Of course people feel better at discharge. The real number is the one we publish at 6 months, 12 months, and 24 months. We are building toward that.

IV · CadenceQ

Published quarterly.

A revised report — with the prior quarter's cohort closed out at six and twelve months — will post here on the first of every quarter. The 2026 Q2 report is scheduled for July 1, 2026.

Clinicians and researchers may request raw, de-identified data via the contact form. The Arc methodology paper is in preparation.